Imexpharm Corporation announced its business results for the first half of the year (H1) on July 18, reporting a 22% year-over-year increase in net revenue and an EBITDA margin of 22%. In H1, ...

Imexpharm, a leader in Vietnam’s pharmaceutical industry, is entering a new growth phase with a focus on the production of invented drugs, leveraging advanced technology to meet stringent ...

Imexpharm Joint Stock Pharmaceutical Company has received the "Vietnam Pharmaceutical Star" award, which honors domestic pharmaceutical companies for significant contributions to healthcare, ...

Imexpharm is pioneering the development of high-tech, high-value-added pharmaceuticals, establishing a solid foundation for sustainable growth both domestically and internationally. Long-term compound ...

Imexpharm Corporation operates as a pharmaceutical company in Vietnam. The company's products include injectable antibiotics, oral antibiotics, cardiovascular, ophthalmology, musculoskeletal system, ...

Imexpharm Corp. advanced stock charts by MarketWatch. View IMP historial stock data and compare to other stocks and exchanges.

Imexpharm Corp (IMP) has delivered a 17.2% change over the past year, with a 52-week range between 36,100.0 and 56,500.0. What Is the Average Daily Trading Volume of Imexpharm Corp (IMP)? The average ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Get the latest Imexpharm Corporation (IMP.VN) stock news and headlines to help you in your trading and investing decisions.

Imexpharm Corp. Annual stock financials by MarketWatch. View the latest IMP financial statements, income statements and financial ratios.